-
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 25 Nov 2024 04:31:10 America/New_York
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has received an average r
Read more...